Pediatric Epilepsy Therapeutics Market
1 Study Coverage
1.1 Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Pediatric Epilepsy Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pediatric Epilepsy Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Pediatric Epilepsy Therapeutics Market Size for the Year 2017-2028
1.3 Pediatric Epilepsy Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Pediatric Epilepsy Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Pediatric Epilepsy Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Pediatric Epilepsy Therapeutics Market Dynamics
1.4.1 Pediatric Epilepsy Therapeutics Industry Trends
1.4.2 Pediatric Epilepsy Therapeutics Market Drivers
1.4.3 Pediatric Epilepsy Therapeutics Market Challenges
1.4.4 Pediatric Epilepsy Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Pediatric Epilepsy Therapeutics by Type
2.1 Pediatric Epilepsy Therapeutics Market Segment by Type
2.1.1 Benign Rolandic Epilepsy
2.1.2 Childhood Absence Epilepsy
2.1.3 Juvenile Myoclonic Epilepsy
2.1.4 Infantile Spasms
2.1.5 Lennox-Gastaut Syndrome
2.2 Global Pediatric Epilepsy Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Pediatric Epilepsy Therapeutics Market Size by Type (2017-2028)
2.4 United States Pediatric Epilepsy Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Pediatric Epilepsy Therapeutics Market Size by Type (2017-2028)
3 Pediatric Epilepsy Therapeutics by Application
3.1 Pediatric Epilepsy Therapeutics Market Segment by Application
3.1.1 Hospitals
3.1.2 Neurology Centers
3.1.3 Home Care Settings
3.1.4 Ambulatory Surgical Centers
3.2 Global Pediatric Epilepsy Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Pediatric Epilepsy Therapeutics Market Size by Application (2017-2028)
3.4 United States Pediatric Epilepsy Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Pediatric Epilepsy Therapeutics Market Size by Application (2017-2028)
4 Global Pediatric Epilepsy Therapeutics Competitor Landscape by Company
4.1 Global Pediatric Epilepsy Therapeutics Market Size by Company
4.1.1 Top Global Pediatric Epilepsy Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Pediatric Epilepsy Therapeutics Revenue by Player (2017-2022)
4.2 Global Pediatric Epilepsy Therapeutics Concentration Ratio (CR)
4.2.1 Pediatric Epilepsy Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Pediatric Epilepsy Therapeutics in 2021
4.2.3 Global Pediatric Epilepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pediatric Epilepsy Therapeutics Headquarters, Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Pediatric Epilepsy Therapeutics Headquarters and Area Served
4.3.2 Global Pediatric Epilepsy Therapeutics Companies Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Pediatric Epilepsy Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Pediatric Epilepsy Therapeutics Market Size by Company
4.5.1 Top Pediatric Epilepsy Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pediatric Epilepsy Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Pediatric Epilepsy Therapeutics Market Size by Region
5.1 Global Pediatric Epilepsy Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pediatric Epilepsy Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Pediatric Epilepsy Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Pediatric Epilepsy Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pediatric Epilepsy Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Pediatric Epilepsy Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pediatric Epilepsy Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pediatric Epilepsy Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Pediatric Epilepsy Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pediatric Epilepsy Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Pediatric Epilepsy Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pediatric Epilepsy Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pediatric Epilepsy Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Details
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Pediatric Epilepsy Therapeutics Introduction
7.1.4 Abbott Laboratories Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)
7.1.5 Abbott Laboratories Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Details
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Pediatric Epilepsy Therapeutics Introduction
7.2.4 GlaxoSmithKline Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)
7.2.5 GlaxoSmithKline Recent Development
7.3 Cephalon
7.3.1 Cephalon Company Details
7.3.2 Cephalon Business Overview
7.3.3 Cephalon Pediatric Epilepsy Therapeutics Introduction
7.3.4 Cephalon Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)
7.3.5 Cephalon Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Details
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Pediatric Epilepsy Therapeutics Introduction
7.4.4 Pfizer Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)
7.4.5 Pfizer Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Pediatric Epilepsy Therapeutics Introduction
7.5.4 Novartis Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)
7.5.5 Novartis Recent Development
7.6 Sunovion Pharmaceuticals
7.6.1 Sunovion Pharmaceuticals Company Details
7.6.2 Sunovion Pharmaceuticals Business Overview
7.6.3 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Introduction
7.6.4 Sunovion Pharmaceuticals Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)
7.6.5 Sunovion Pharmaceuticals Recent Development
7.7 Bausch Health
7.7.1 Bausch Health Company Details
7.7.2 Bausch Health Business Overview
7.7.3 Bausch Health Pediatric Epilepsy Therapeutics Introduction
7.7.4 Bausch Health Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)
7.7.5 Bausch Health Recent Development
7.8 Sanofi
7.8.1 Sanofi Company Details
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Pediatric Epilepsy Therapeutics Introduction
7.8.4 Sanofi Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)
7.8.5 Sanofi Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Pediatric Epilepsy Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Pediatric Epilepsy Therapeutics Market Trends
Table 3. Pediatric Epilepsy Therapeutics Market Drivers
Table 4. Pediatric Epilepsy Therapeutics Market Challenges
Table 5. Pediatric Epilepsy Therapeutics Market Restraints
Table 6. Global Pediatric Epilepsy Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pediatric Epilepsy Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pediatric Epilepsy Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pediatric Epilepsy Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pediatric Epilepsy Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Pediatric Epilepsy Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Pediatric Epilepsy Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Pediatric Epilepsy Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Epilepsy Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Epilepsy Therapeutics as of 2021)
Table 15. Top Players of Pediatric Epilepsy Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Pediatric Epilepsy Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Pediatric Epilepsy Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Pediatric Epilepsy Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Pediatric Epilepsy Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Pediatric Epilepsy Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Pediatric Epilepsy Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Pediatric Epilepsy Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Pediatric Epilepsy Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Pediatric Epilepsy Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Pediatric Epilepsy Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Pediatric Epilepsy Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Pediatric Epilepsy Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Abbott Laboratories Company Details
Table 31. Abbott Laboratories Business Overview
Table 32. Abbott Laboratories Pediatric Epilepsy Therapeutics Product
Table 33. Abbott Laboratories Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Abbott Laboratories Recent Development
Table 35. GlaxoSmithKline Company Details
Table 36. GlaxoSmithKline Business Overview
Table 37. GlaxoSmithKline Pediatric Epilepsy Therapeutics Product
Table 38. GlaxoSmithKline Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
Table 39. GlaxoSmithKline Recent Development
Table 40. Cephalon Company Details
Table 41. Cephalon Business Overview
Table 42. Cephalon Pediatric Epilepsy Therapeutics Product
Table 43. Cephalon Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Cephalon Recent Development
Table 45. Pfizer Company Details
Table 46. Pfizer Business Overview
Table 47. Pfizer Pediatric Epilepsy Therapeutics Product
Table 48. Pfizer Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Pfizer Recent Development
Table 50. Novartis Company Details
Table 51. Novartis Business Overview
Table 52. Novartis Pediatric Epilepsy Therapeutics Product
Table 53. Novartis Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Sunovion Pharmaceuticals Company Details
Table 56. Sunovion Pharmaceuticals Business Overview
Table 57. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Product
Table 58. Sunovion Pharmaceuticals Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Sunovion Pharmaceuticals Recent Development
Table 60. Bausch Health Company Details
Table 61. Bausch Health Business Overview
Table 62. Bausch Health Pediatric Epilepsy Therapeutics Product
Table 63. Bausch Health Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Bausch Health Recent Development
Table 65. Sanofi Company Details
Table 66. Sanofi Business Overview
Table 67. Sanofi Pediatric Epilepsy Therapeutics Product
Table 68. Sanofi Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Sanofi Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Epilepsy Therapeutics Product Picture
Figure 2. Global Pediatric Epilepsy Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pediatric Epilepsy Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Pediatric Epilepsy Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Pediatric Epilepsy Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Pediatric Epilepsy Therapeutics Market Share in Global 2017-2028
Figure 7. Pediatric Epilepsy Therapeutics Report Years Considered
Figure 8. Product Picture of Benign Rolandic Epilepsy
Figure 9. Product Picture of Childhood Absence Epilepsy
Figure 10. Product Picture of Juvenile Myoclonic Epilepsy
Figure 11. Product Picture of Infantile Spasms
Figure 12. Product Picture of Lennox-Gastaut Syndrome
Figure 13. Global Pediatric Epilepsy Therapeutics Market Share by Type in 2022 & 2028
Figure 14. Global Pediatric Epilepsy Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global Pediatric Epilepsy Therapeutics Market Share by Type (2017-2028)
Figure 16. United States Pediatric Epilepsy Therapeutics Market Share by Type in 2022 & 2028
Figure 17. United States Pediatric Epilepsy Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States Pediatric Epilepsy Therapeutics Market Share by Type (2017-2028)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Neurology Centers
Figure 21. Product Picture of Home Care Settings
Figure 22. Product Picture of Ambulatory Surgical Centers
Figure 23. Global Pediatric Epilepsy Therapeutics Market Share by Application in 2022 & 2028
Figure 24. Global Pediatric Epilepsy Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 25. Global Pediatric Epilepsy Therapeutics Market Share by Application (2017-2028)
Figure 26. United States Pediatric Epilepsy Therapeutics Market Share by Application in 2022 & 2028
Figure 27. United States Pediatric Epilepsy Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 28. United States Pediatric Epilepsy Therapeutics Market Share by Application (2017-2028)
Figure 29. North America Pediatric Epilepsy Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. U.S. Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Canada Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Europe Pediatric Epilepsy Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. Germany Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. France Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. U.K. Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Italy Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Russia Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Pediatric Epilepsy Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 39. China Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Japan Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. South Korea Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. India Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Australia Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Taiwan Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Indonesia Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Thailand Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Malaysia Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Philippines Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Latin America Pediatric Epilepsy Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Mexico Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Brazil Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Argentina Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Pediatric Epilepsy Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 54. Turkey Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. U.A.E Pediatric Epilepsy Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)
Figure 59. Cephalon Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)
Figure 60. Pfizer Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)
Figure 62. Sunovion Pharmaceuticals Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)
Figure 63. Bausch Health Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)
Figure 64. Sanofi Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Industry Market Size
